Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-24

Clinical Trial Update: Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial update investigating whether dexmedetomidine can reduce delirium and postoperative cognitive dysfunction after op…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Delirium, Postoperative Cognitive Dysfunction | Phase 4 | Status: ACTIVE_NOT_RECRUITING